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A B S T R A C T
Autism is a pervasive developmental disorder characterised by impairment in social interaction and communication,
with unusual behavior. In some cases the pharmacotherapy is prescribed and the most studied antipshychotic drugs in-
clude haloperidol and risperidone. In this paper we displayed the treatment of two cases of autism in boy and girl with
risperidone. With the use of risperidone in girl, we have achieved reduction of psychomotor symptoms and reduction of
hetero-aggressive and self-destructive behavior, and in boy we have also achieved reduction of psychomotoric symptoms,
with improvement in contact with his surrounding, he had less learning problems and he has felt familiar not only with
his mother, but with other persons. Research on the use of risperidone in the treatment of autistic disorders among chil-
dren in Croatia are rare, given the limited use of risperidone in children younger than 15 years, the question arises about
the need to expand the scope of application of risperidone in younger age groups.
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Introduction
Autism is a pervasive developmental disorder charac-
terised by impairment in social interaction and commu-
nication, with unusual behaviour1.
Autistic disorder is believed to occur at a rate of about
five cases per 10 000 children (0.05 percent). The onset of
autistic disorder is before the age of 3 years and is four to
five times more frequent in boys than in girls. Girls with
autism are more likely to have more severe mental retar-
dation. The causes of autism spectrum disorders are un-
known, although genetic and environmental influence
have been implicated. There is increasing evidence that
people with autism spectrum disorder have abnormali-
ties in the serotonergic system2,3.
There are limited options for pharmacological thera-
peutic interventions in children with autism disorders
and some studies showed that risperidone as an atypical
antipsychotic may be effective for the treatment of peo-
ple with autism and intellectual disabilities4.
The most studied antipshychotic drugs include halo-
peridol and risperidone5. In low dosages, they have been
shown to reduce repetitive behaviors (stereotypes) and
social withdrawal, as well as a number of related symp-
toms, such as a hyperactivity, aggression, self-abuse be-
havior, liability of mood and irritability. All the listed
symptoms have appeared in adult patients with schizo-
phrenia, where also with the application of atypic anti-
psychotics may affect on described clinical picture6.
70% of children have mild to moderate learning dis-
ability, the remaining 30 % with normal IQ are classified
as either high-functioning autism (with language diffi-
culties) or Asperger´s syndrome (with normal language).
1–2 % of those with autism have a normal life; 5 to 20 %
of those with autism have a borderline prognosis; but 70
% are totally dependent upon support7.
In this paper we displayed two cases of autism in boy
and girl with confirmed diagnosis of autism according to
DSM-IV (Diagnostic and Statistical Manual of Mental
Disorders), ICD-10 (International Statistical Classifica-
tion of Diseases and Related Health Problems) classifica-
tion criteria.
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Example number 1
NN is a girl born in complete family as the youngest
child of four children. The oldest sister was treated by
psychiatrist because of enuresis and encopresis.
Pregnancy and childbirth have passed without any
problems. Body weight after birth was 3450 grams and
body height was 50 centimeters. Girl regularly received
all necessary vaccines, she did not have any of pediatric
infectious diseases. She started walking with ten months,
she began to speak with twelve months of age, but before
she came to the first psychiatric examination (at the age
of five years) she did not establish control of sphincters.
First review by the psychiatrist was in 1997 year at
the age of five years. The mother brought her child be-
cause she was seemed that the girl was »hyperactive«.
Mother described that the girl was not sleeping during
the night, frequently was awaken, she was restless, con-
stantly had the need to touch things and people, was
afraid to stay alone and sought the light. She often cried
at night, if something was not according to her gnawed at
her hands, struck the head of the table, two months be-
fore the review she has rejected to communicate, and
people in surrounding area have found that she was less
communicative in relation to other children of her age.
She was disturbed by sounds, covered her ears with
hands, screamed, struck the head of the wall, swung and
swayed like pendulum, refused to play with peers. We
have found that the all listed symptoms started at the
age of less than three years. She has also reacted to chan-
ges at home, such as changes in the position of furniture
with frequent patterns of self-destructive behavior.
The only words pronounced by her were »mom« and
»dad« and only in communication with toddlers, with the
others she did not communicate. Every night she was
enuretic and when she was angry struck the head of the
floor. We have also noticed an increase in body weight,
the mother alleged that the girl had a stronger appetite.
She often gnawed her hands while being wounded, so we
had to wraped her hands that they can not easily hurt.
At the age of 5 years treatment started with halo-
peridol (1/mg in the morning and 1/mg at the evening)
with lower doses of anxiolytics and then we noticed that
the girl was calm, but still uninterested in the environ-
ment and play with peers. Haloperidol dose was in-
creased to 2 mg three times a day when the girl was five
and a half. After examining the medical records, it was
evident that the girl regularly had outpatient treatment
at child’s psychiatrist during following three years, with
minimum correction therapy (haloperidol, diazepam, oxa-
zepam). From the described behavior it was evident that
the girl was a bit calmer, but still liked throwing things
around the house, could not stay alone without parental
supervision, enjoyed watching her mother cooking, wat-
ched just commercials on tv, she was less aggressive, she
did not trash her head anymore and sometimes she
stayed alone in the bedroom.
At that time she was taking the recommended ther-
apy of haloperidol 2,5 mg two times a day with lower
doses of anxiolytics. At the age of eight, 3 mg dose of
risperidone was introduced in place of haloperidol in the
evening.
The reason for the change in therapy was the occu-
rence of tics and stereotypes (possible adverse effects of
haloperidol). The family said that the phenomenon of
tics increases aggressive behavior in girl, during the
night constantly wet the bed, tend to frequent night
awakening. Evaluation is done by psychologist and the
IQ level was 33. The finding was noted that there are se-
rious intellectual damage and that the person is totally
incapable of independent life and requires continuous
care from other persons.
After the introduction of risperidone, girl was psycho-
motorically more tranquil, rarely behaved self-destruc-
tive, better sleep, but still indifferent for surrounding
and daily events, more time was carried out in the room,
usually near her mother and sister and still was needed
to wrap her hands.In the therapy was introduced mepro-
bamate in the dosage of three times a day.
At the age of nine years, mother said that the girl dur-
ing the day was more tranquil, but still did intentional
self-injury (was observed bruises by the body, continually
held hands in the mouth, was less aggressive towards
family members, except when they hindering her to
make self-inflicted injury (therapy: risperidone, biperi-
din, meprobamate).
At the age between nine and ten years was continued
outpatient psychiatric treatment, but due to enhanced
autodestructivity, in the therapy was re-introduced halo-
peridol with promazin and diazepam. On several occa-
sions was made the laboratory control of lipids and liver
enzymes: the values were within the reference ranges.
Withe regard to the increasing fear and avoidance of the
outside world, the family became increasingly difficult to
bring a girl on the reviews. At the age of 13 years was no-
ticed that the girl has increased whole body tremor, not
went outside and one year after, familiy has managed to
bring the girl to the control examination. In the therapy
was re-introduced risperidone in dosage of four mg daily,
divided in two doses, with lower levels of anxyolitics.
At the age between 14 and 15 years according to the
existing outpatient documentation it was shown, that
the girl during this period of time was psychomotorically
more tranquil, had better sleep, but she was completely
dysfunctional when it comes to her social and working
life, she was dependent on others and their continuing
care. Diagnosis was autism with a very high risk from
self-inflicted injure.
Chronological review of therapeutic interventions in
girl is shown in Table 1.
Example number 2
MM is a boy and the only child in primary family.
First psychiatric examination was at the age of 6
years.
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According to anamnestic findings, mother’s preg-
nancy was burdened by constant conflicts with the hus-
band, who was opposed to pregnancy, allegedly now ac-
cepted boy. During pregnancy the mother has taken
diazepam.
By birth, boy spent some time in the incubator for dif-
ficulty breathing, after three weeks was released to home
care. He started to walk with fourteen months, spoke
with two years. To third year of life established sphincter
control. The same year began to attend children’s nurs-
ery, but with many difficulties. In the children’s nursery
was restless, behaved hyperactive, disobedient, often in
conflicts with other children, and governess recomended
them to seek help. We found out from the family that the
boy at the age of two years had difficulties with sedation
and his mother had to hold him by the hand and swing
him. He expressed tics of the head, especially the move-
ments of the eyes and lips. As a small child on several oc-
casions he bited out lower lip to the blood. During his
stay in children’s nursery, all the time awaited his par-
ents at the window, less communicate with peers. He did
not play with toys the same way as the other children.
Parents have learned him all the letters and numbers up
to hundred when he was five years, easy to remember all
the songs by heart, but could not ditinguish colors. In a
children’s nursery it was noticed that he did not know
draw, rejected to sit quietly in one place, for a longer
time. Sometimes for no reason at all said something,
spoke puzzlingly, without a motive and then can not re-
member what was uttered.
It was observed that the boy’s mother had lower mood
level, weepy, scared, and the father of the boy was extre-
mly negativistic, he did not want to help, emotionally
cold and restrained toward the boy. Additionally, mother
described a number of adverse family circumstances which
further affect her psychological functioning (co-existence
with father-in-low, aggressive brother-in low).Working
diagnosis was hyperkinetic disorder and in the therapy
was introduced sulpiride and vitamine B complex. Dur-
ing the following control was found irregularly taking
medications, it was stated that the boy was still hyperac-
tive, hardly held attention, protruded the tongue, bited
lower lip, touched objects in the room, had a constant
need to touches certain things or people around himself
and upon arrival at kindergarten, mother have allways
found himself alone, without the society of children. He
was included in the individualized work with psycholo-
gist and defectologist, with the control examinations by
psychiatrist.
Mother was motivated to cooperate, she was con-
stantly in touch with the latest literature, has read about
disorders that were noticed in boy, she was very moti-
vated for any kind of help. In the boy were significantly
expressed stereotype actions, neologisms, hardly fits in
the group of peers, they did not accept him, described
him as a bizarre.
At the age of 6 years, first psychological tests were
made and described uneven intelectuall development in
the broad limits of average, under developed graphomo-
toric skills. Psychological retest displayed under average
global intellectual development (IQ was 70), child started
first grade of primary school with an adjusted progra-
mme. In the school he displayed a number of characteris-
tics of poor adaptation, tics and grimacing were empha-
sized, and pharmacotherapy was introduced.
At the age of nine years in the therapy was introduced
risperidon at a dose of 0.5 ml in the evening (liquid form).
During the control examinations because of psychomo-
toric disturbance and sleep disturbances, in the therapy
was also included diazepam at a dose of 2 mg in the
morning and afternoon and 5/mg in the evening. Patient
became psychomotorically more tranquil, with better
sleep, but still expressed tics, stereotypes, oscillations in
the mood, separation fears. It was made elaboration, be-
cause of selection of adequate education forms, and was
recommended individualized approach with adapted prog-
ramme. Therapy for further treatment is risperidon at a
dose of two ml daily and diazepam as required.
At the age of ten years, was done retest by psycholo-
gist, psychological retest displayed global intellectual
functions at the level of mild mental retardation, child
was moved to a school with special conditions and contin-
uing education under special programme.
Subsequently testing continued in Zagreb at the age
of eleven years and set suspected to hyperkinetic disor-
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TABLE 1
PSYCHIATRIC INTERVENTIONS IN GIRL DEPENDING ON
AGE – EXAMPLE NUMBER 1
Age Psychiatric interventions
<3 years First observed symptoms of disease by
parents
5 years First review by child psychiatrist
5 years Haloperidol – 1 mg twice daily
half past five years Haloperidol – 2 mg three times a day
6 years Haloperidol – 2,5 mg twice daily
anxiolytics – lower doses
8 years Risperidone – 3 mg in the evening
9 years Risperidone meprobamate biperidin
>13 years Risperidone – 4 mg in two divided doses
TABLE 2
PSYCHIATRIC INTERVENTIONS IN BOY DEPENDING ON
AGE – EXAMPLE NUMBER 2
Age Psychiatric interventions
<3 years First symptoms
6 years First examination by child psychiatrist IQ=70
sulpiride and B vitamines as a therapy
9 years Risperidone liquid – 0.5 ml in the evening
10 years Mild mental retardation
11 years EEG – irritative changes
13 years Diazepam – 2 mg in the morning and afternoon
and 5 mg in the evening risperidone liquid – 2 ml
once a day
der, Tourette syndrome and epilepsia-incomplete differ-
ential diagnosis (MRI of brain was within the limits of
normal, EEG irritative changes).
n the contrary he has overcome some abstract skills
such as playing chess (he also learned the alphabet be-
tween second and third years of age and many other
informations), but with weaker follow-up of a story con-
tent, less understanding of social interactions.
Given results besides of disharmonic, confirmed also
a slow pace of cognitive maturation, through a series of
features of pervasive develomental disorder, highly func-
tioning type of child with autism.
Chronological review of therapeutic interventions in
boy is shown in Table 2.
Discussion
The both first and second-generation antipsychotics
have shown safety and efficacy in short-and long-term
studies in autism. Safety concerns associated with treat-
ment include the risk of drug-related dyskinesias, which
is greater with the first-generation drugs (haloperidol,
flufenazin), and the risk of weight gain and associated
metabolic problems (increases in glucose and lipids),
which is greater with the second generation agents8.
Risperidone has been shown to reduce repetitive be-
haviors and social withdrawal, hyperactivity, aggression,
self-harm behavior, temper tantrums, liability of mood
and irritability6. It is also has been proved helpful in
treating children and adolescents with autism spectrum,
conduct and bipolar disorder, Tourette’s syndrome and
schizophrenia9. Risperidone is a high potency antipsy-
chotic with combined dopamine D2 and serotonin 5-HT2
receptor antagonist properties, has been used to subdue
aggressive or self-injurious behaviors. Several reports
have suggested that risperidone is effective in diminish-
ing aggressiveness, hyperactivity and self-injurious be-
havior in children with autistic disorder. For children
with autism, lower dosages ranging from 0.5 to 4 mg per
day are generally used10. Treatment with atypical anti-
psychotic olanzapine also can be beneficial in alleviating
some behavioral symptoms (irritability, hyperactivity/non-
compliance, lethargy), associated with autism11.
The average dose of risperidone in presented cases
was between two and four mg per day. It is very impor-
tant careful drug titration, usually start with half (½) or
one (1) mg in the morning, and than gradually increase
the dose in order to prevent adverse effects12.
It is important to educate parents of children about
possible side effects of treatment with antipsychotics.
Most often side effects are feeling of stiffness, primarily
in the neck and spinal muscles, sedation and weight gain.
In rare cases also galactorrhoea. This approach can help
parents to distinguish between symptoms of disorder
and adverse drug effects, reduce their anxiety and intimi-
dation, and simultaneously upgrade compliance and trust
between parent and child.
In the section about the girl, example number 1, a
combination of risperidone and lower doses of anxiolytics
have been successful in reducing self-inflicted injuries,
bouts of aggression and stereotypes, but still largely
marked social inhibition, inability to achieve contact
with the environment and any involvement in the school
environment. It is hampered continuous arrival of girl at
the regular psychiatric reviews, because it is observed
that during his stay with other children in the waiting
room the girl became very agitated, self-destructive, par-
ents have trouble controlling her behavior and reactions.
Now girl has eightteen years, remains on treatment with
risperidon, with regard to the clinical picture described
and marked side-effects from the typical antipsychotic
haloperidol (tics, tremor, stereotypes), she has got an ap-
proval by the competent committees at the Croatian In-
stitute for Health Insurance to continue treatment with
risperidon at a dose of four mg daily. Prognosis is very
uncertain.
In the section about the boy, example number 2, we
have also managed to reduce hyperactivity with risperi-
done, partially improved his attention and concentra-
tion, and it is possible through a program tailored to his
abilities, attempts to implement school training. How-
ever, it is still present social inhibition, more difficult in-
clusion into group of peers and making contacts with
other children.
With the presented cases, we have tried to show how
difficult is to treat autistic children, because there are ex-
tremely limited opportunities for intervention with med-
ications, according to a survey of literature, in the first
place are mentioned risperidone and haloperidol. These
medications are usually studied in adult schizophrenic
patients, and there are frequent dilemmas on the use of
this group of drugs in children. It is important to always
take into account the adverse effects of this group of
drugs, time to inform parents about them and have con-
tinuous monitoring of children. We have noticed that is
often required professional assistance to parents of such
children, because of the constant confrontation with dif-
ficulties and unpredictable course of illness and fear of
the uncertain future of their children.
Conclusion
Antipsychotics as drugs are intended primarily for
the treatment of adult patients with psychotic disorders,
but showed a favorable effects on the symptoms in autis-
tic children, especially risperidone. Some studies indicate
that the earlier use of antipsychotics in autistic children
may have protective effect on IQ, which further justifies
the use of these drugs in early childhood13. Research on
the use of risperidone in the treatment of autistic disor-
ders among children in Croatia are rare, given the lim-
ited use of risperidone in children younger than 15 years,
the question arises about the need to expand the scope of
application of risperidone in younger age groups.
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LIJE^ENJE AUTISTI^NE DJECE RISPERIDONOM
S A @ E T A K
Autizam je pervazivni razvojni poreme}aj, obilje`en o{te}enom socijalnom interakcijom i komunikacijom i neobi~nim
pona{anjem. Pojedini slu~ajevi su zahtijevali farmakolo{ko lije~enje, a najistra`ivaniji lijekovi za lije~enje autizma kod
djece su antispihotici risperidon i haloperidol. U ovom radu smo prikazali lije~enje dva slu~aja djece s autizmom primje-
nom risperidona. Kod djevojke smo smanjili psihomotori~ke pote{ko}e, heterodestruktivno i autodestruktivno pona{a-
nje, a kod dje~aka smo smanjili psihomotorne smetnje, pobolj{ali smo kontakt sa okolinom, ubla`ili smetnje u~enja i
omogu}ili da funkcionira i u dru{tvu ostalih osoba, a ne samo unutar obitelji. Istra`ivanja o uporabi risperidona u
lije~enju autisti~nih poreme}aja kod djece u Hrvatskoj su rijetka, a s obzirom na ograni~enost uporabe risperidona za
djecu mla|u od 15 godina, postavlja se pitanje o potrebi pro{irenja indikacijskog podru~ja uporabe risperidona kod
mla|ih dobnih skupina.
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